Jump to content

Lomevactone

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Monkbot (talk | contribs) at 22:38, 3 December 2020 (Task 18 (cosmetic): eval 2 templates: del empty params (4×);). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Lomevactone
Clinical data
ATC code
  • None
Identifiers
  • (3R,4S,6R)-4-(4-chlorophenyl)-6-methyl-3-phenyltetrahydro-2H-pyran-2-one
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC18H17ClO2
Molar mass300.78 g·mol−1
3D model (JSmol)
  • Clc1ccc(cc1)C2C(C(=O)OC(C)C2)c3ccccc3

Lomevactone (INN) (developmental code name DR-250) is a drug described as a psychostimulant and antidepressant which was synthesized and assayed in the 1980s but was never marketed.[1][2]

References

  1. ^ David J. Triggle (1997). Dictionary of pharmacological agents. London: Chapman & Hall. ISBN 0-412-46630-9.
  2. ^ Poncelet M, Chermat R, Soubrie P, Simon P (1983). "The progressive ratio schedule as a model for studying the psychomotor stimulant activity of drugs in the rat". Psychopharmacology. 80 (2): 184–9. doi:10.1007/BF00427967. PMID 6136063. S2CID 2372145.
Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Lomevactone&oldid=992179327"